Improved efficacy of doxorubicin delivery by a novel dual-ligand-modified liposome in hepatocellular carcinoma.
Li X, Diao W, Xue H, Wu F, Wang W, Jiang B, Bai J, Lian B, Feng W, Sun T, Yu W, Wu J, Qu M, Wang Y, Gao Z.
Li X, et al. Among authors: lian b.
Cancer Lett. 2020 Oct 1;489:163-173. doi: 10.1016/j.canlet.2020.06.017. Epub 2020 Jun 25.
Cancer Lett. 2020.
PMID: 32592729